Working capital -- $8.7 million in working capital, up from $2.4 million as of September 30, 2024. Debt -- No outstanding debt as of June 30, 2025. Guidance -- Fiscal 2025 product revenue is expected ...
Product revenue-- $1.7 million, up 105% year over year, with management stating continued ramp expected through year-end. Product gross margin-- Increased to 53.9% from 34.1% year over year. Full-year ...
Hosted on MSN
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q3 2025 Earnings Call Transcript
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q3 2025 Earnings Call Transcript August 14, 2025 NeuroOne Medical Technologies Corporation beats earnings expectations. Reported EPS is $-0.03, ...
Good day, ladies and gentlemen. Welcome to the Third Quarter of Fiscal Year 2025 and financial results conference Call for NeuroOne Medical Technologies Corporation. Today's call will be conducted by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results